Question normal

Dr. Julie Gerberding is Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, and Population Health at Merck & Co., Inc., where she also has responsibility for the “Merck for Mothers” global program to prevent maternal mortality and the Merck Foundation. She joined Merck in January 2010 as president of Merck Vaccines and led efforts to make the company’s vaccines more available and affordable to people in resource-limited countries around the world.

Gerberding in the news: mercknewsroom.com/news-release...

Dr. Gerberding’s talk at #APSA17 will be on Saturday, April 22nd at 4:00-4:30pm.

Register today! Early bird pricing ends March 10.
More info: meeting.physicianscientists.or...
Dr. Gerberding’s legacy at the CDC: healthimpactnews.com/2015/form...

Dr. Gerberding’s talk at #APSA17 is at 4:00-4:30pm on 4/22

mercknewsroom.com/news-release...